Price-T-Rowe-Associates-Inc-Md

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
4,506
Total Value
811609461
Accession Number
0000080255-25-000284
Form Type
13F-HR
Manager Name
Price-T-Rowe-Associates-Inc-Md
Data Enrichment
96% identified
4,322 identified184 unidentified

Holdings

4,506 positions • $811.6M total value
Manager:
Search and click to pin securities to the top
Page 131 of 152
Cytek Biosciences, Inc.
Shares:53.3K
Value:$214.0K
% of Portfolio:0.0% ($214.0K/$811.6M)
FORUM ENERGY TECHNOLOGIES, INC.
Shares:10.6K
Value:$213.0K
% of Portfolio:0.0% ($213.0K/$811.6M)
Sleep Number Corp
Shares:33.6K
Value:$213.0K
% of Portfolio:0.0% ($213.0K/$811.6M)
GREAT SOUTHERN BANCORP, INC.
Shares:3.8K
Value:$213.0K
% of Portfolio:0.0% ($213.0K/$811.6M)
RUSH ENTERPRISES INC \TX\
Shares:3.8K
Value:$213.0K
% of Portfolio:0.0% ($213.0K/$811.6M)
Repay Holdings Corp
Shares:38.1K
Value:$213.0K
% of Portfolio:0.0% ($213.0K/$811.6M)
Lovesac Co
Shares:11.6K
Value:$212.0K
% of Portfolio:0.0% ($212.0K/$811.6M)
STANDARD BIOTOOLS INC.
Shares:195.5K
Value:$212.0K
% of Portfolio:0.0% ($212.0K/$811.6M)
Terns Pharmaceuticals, Inc.
Shares:76.1K
Value:$210.0K
% of Portfolio:0.0% ($210.0K/$811.6M)
Kura Oncology, Inc.
Shares:31.7K
Value:$210.0K
% of Portfolio:0.0% ($210.0K/$811.6M)
MILLER INDUSTRIES INC /TN/
Shares:4.9K
Value:$209.0K
% of Portfolio:0.0% ($209.0K/$811.6M)
KULR Technology Group, Inc.
Shares:157.9K
Value:$209.0K
% of Portfolio:0.0% ($209.0K/$811.6M)
Canterbury Park Holding Corp
Shares:11.4K
Value:$208.0K
% of Portfolio:0.0% ($208.0K/$811.6M)
CANTALOUPE, INC.
Shares:26.4K
Value:$208.0K
% of Portfolio:0.0% ($208.0K/$811.6M)
FINANCIAL INSTITUTIONS INC
Shares:8.3K
Value:$207.0K
% of Portfolio:0.0% ($207.0K/$811.6M)
Peakstone Realty Trust
Shares:16.2K
Value:$205.0K
% of Portfolio:0.0% ($205.0K/$811.6M)
FARMERS NATIONAL BANC CORP /OH/
Shares:15.7K
Value:$205.0K
% of Portfolio:0.0% ($205.0K/$811.6M)
Excelerate Energy, Inc.
Shares:7.1K
Value:$205.0K
% of Portfolio:0.0% ($205.0K/$811.6M)
CNB FINANCIAL CORP/PA
Shares:9.2K
Value:$205.0K
% of Portfolio:0.0% ($205.0K/$811.6M)
Amylyx Pharmaceuticals, Inc.
Shares:57.7K
Value:$205.0K
% of Portfolio:0.0% ($205.0K/$811.6M)